Mar-cetirizine 20 Mg Tablet: Out Of Specification (impurities)
Recall Summary MAR-Cetirizine 20 mg tablets are being recalled across Canada because they contain impurities that don't meet quality standards. This recall affects all cetirizine 20 mg tablets distributed under the MAR brand in Canada. The issue was classified as a serious quality defect.
- Product
- MAR-Cetirizine 20 mg tablet
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-03-20
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/e0d209af-332f-474b-9dda-593631f63795